These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9632348)

  • 21. CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound.
    Forbes IT; Cooper DG; Dodds EK; Hickey DM; Ife RJ; Meeson M; Stockley M; Berkhout TA; Gohil J; Groot PH; Moores K
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1803-6. PubMed ID: 10969972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of receptor and receptor subtype affinities using diastereomeric and enantiomeric monosaccharide scaffolds as a means to structural and biological diversity. A new route to ether synthesis.
    Hirschmann R; Hynes J; Cichy-Knight MA; van Rijn RD; Sprengeler PA; Spoors PG; Shakespeare WC; Pietranico-Cole S; Barbosa J; Liu J; Yao W; Rohrer S; Smith AB
    J Med Chem; 1998 Apr; 41(9):1382-91. PubMed ID: 9554871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-secretory properties of non-peptide somatostatin receptor agonists in isolated rat colon: luminal activity and possible interaction with P-glycoprotein.
    Emery PT; Higgs NB; Warhurst AC; Carlson GL; Warhurst G
    Br J Pharmacol; 2002 Mar; 135(6):1443-8. PubMed ID: 11906957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of growth hormone and prolactin gene expression and secretion by chimeric somatostatin-dopamine molecules.
    Gruszka A; Ren SG; Dong J; Culler MD; Melmed S
    Endocrinology; 2007 Dec; 148(12):6107-14. PubMed ID: 17656461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel non-peptide ligands for the somatostatin sst3 receptor.
    Moinet C; Contour-Galcéra MO; Poitout L; Morgan B; Gordon T; Rouber P; Thurieau C
    Bioorg Med Chem Lett; 2001 Apr; 11(8):991-5. PubMed ID: 11327607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists.
    Cole DC; Lennox WJ; Lombardi S; Ellingboe JW; Bernotas RC; Tawa GJ; Mazandarani H; Smith DL; Zhang G; Coupet J; Schechter LE
    J Med Chem; 2005 Jan; 48(2):353-6. PubMed ID: 15658848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of substituted imidazopyrazines as ligands for the human somatostatin receptor subtype 5.
    Contour-Galéra MO; Poitout L; Moinet C; Morgan B; Gordon T; Roubert P; Thurieau C
    Bioorg Med Chem Lett; 2001 Mar; 11(5):741-5. PubMed ID: 11266182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-[2(R)-(2-amino-2-methylpropionylamino)-3-(1H-indol-3-yl)propionyl]- 3-benzylpiperidine-3(S)-carboxylic acid ethyl ester (L-163,540): a potent, orally bioavailable, and short-duration growth hormone secretagogue.
    Yang L; Morriello G; Patchett AA; Leung K; Jacks T; Cheng K; Schleim KD; Feeney W; Chan WW; Chiu SH; Smith RG
    J Med Chem; 1998 Jul; 41(14):2439-41. PubMed ID: 9651148
    [No Abstract]   [Full Text] [Related]  

  • 29. Somatostatin displayed on filamentous phage as a receptor-specific agonist.
    Rousch M; Lutgerink JT; Coote J; de Bruïne A; Arends JW; Hoogenboom HR
    Br J Pharmacol; 1998 Sep; 125(1):5-16. PubMed ID: 9776337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists.
    Guo L; Ye Z; Liu J; He S; Bakshi RK; Sebhat IK; Dobbelaar PH; Hong Q; Jian T; Dellureficio JP; Tsou NN; Ball RG; Weinberg DH; MacNeil T; Tang R; Tamvakopoulos C; Peng Q; Chen HY; Chen AS; Martin WJ; MacIntyre DE; Strack AM; Fong TM; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4895-900. PubMed ID: 20621473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures.
    Djordjijevic D; Zhang J; Priam M; Viollet C; Gourdji D; Kordon C; Epelbaum J
    Endocrinology; 1998 May; 139(5):2272-7. PubMed ID: 9564833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonists.
    Palin R; Barn DR; Clark JK; Cottney JE; Cowley PM; Crockatt M; Evans L; Feilden H; Goodwin RR; Griekspoor F; Grove SJ; Houghton AK; Jones PS; Morphy RJ; Smith AR; Sundaram H; Vrolijk D; Weston MA; Wishart G; Wren P
    Bioorg Med Chem Lett; 2005 Feb; 15(3):589-93. PubMed ID: 15664818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatostatin-induced control of cytosolic free calcium in pituitary tumour cells.
    Petrucci C; Cervia D; Buzzi M; Biondi C; Bagnoli P
    Br J Pharmacol; 2000 Feb; 129(3):471-84. PubMed ID: 10711345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.
    Martin RE; Mohr P; Maerki HP; Guba W; Kuratli C; Gavelle O; Binggeli A; Bendels S; Alvarez-Sánchez R; Alker A; Polonchuk L; Christ AD
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6106-13. PubMed ID: 19786348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (4-Piperidin-1-yl)phenyl amides: potent and selective human beta(3) agonists.
    Hu B; Ellingboe J; Han S; Largis E; Mulvey R; Oliphant A; Sum FW; Tillett J
    J Med Chem; 2001 Apr; 44(9):1456-66. PubMed ID: 11311069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective regulation of somatostatin receptor subtype signaling: evidence for constitutive receptor activation.
    Ben-Shlomo A; Pichurin O; Barshop NJ; Wawrowsky KA; Taylor J; Culler MD; Chesnokova V; Liu NA; Melmed S
    Mol Endocrinol; 2007 Oct; 21(10):2565-78. PubMed ID: 17609435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug design at peptide receptors: somatostatin receptor ligands.
    Hannon JP; Nunn C; Stolz B; Bruns C; Weckbecker G; Lewis I; Troxler T; Hurth K; Hoyer D
    J Mol Neurosci; 2002; 18(1-2):15-27. PubMed ID: 11931345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonists.
    Witherington J; Bordas V; Cooper DG; Forbes IT; Gribble AD; Ife RJ; Berkhout T; Gohil J; Groot PH
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2177-80. PubMed ID: 11514164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential involvement of signaling pathways in the regulation of growth hormone release by somatostatin and growth hormone-releasing hormone in orange-spotted grouper (Epinephelus coioides).
    Wang B; Qin C; Zhang C; Jia J; Sun C; Li W
    Mol Cell Endocrinol; 2014 Feb; 382(2):851-9. PubMed ID: 24183819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spirovesamicols: conformationally restricted analogs of 2-(4-phenylpiperidino)cyclohexanol (vesamicol, AH5183) as potential modulators of presynaptic cholinergic function.
    Efange SM; Khare AB; Foulon C; Akella SK; Parsons SM
    J Med Chem; 1994 Aug; 37(16):2574-82. PubMed ID: 8057300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.